NSC |
Compound |
Enrichment |
Correlation |
NSC 623527 |
Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt |
0.00289834947687851 |
0.22048937 |
NSC 650263 |
Null |
0.00289834947687851 |
0.010536814 |
NSC 685014 |
Null |
0.00289834947687851 |
0.32677231 |
NSC 718728 |
5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide |
0.00289834947687851 |
0.60203966 |
NSC 620327 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.00334162892839391 |
-0.24224767 |
NSC 639520 |
Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.00334162892839391 |
0.28944852 |
NSC 114346 |
Null |
0.00337662564965909 |
0.700653 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00337662564965909 |
0.44914787 |
NSC 269720 |
Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- |
0.00337662564965909 |
0.27251093 |
NSC 638409 |
(E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide |
0.00337662564965909 |
0.6352346 |